Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
SEER
#3273
Seer, Inc. Class A Common Stock
1.7
2
-16.50%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-16.50%
Aylık değişim
-9.47%
6 aylık değişim
-16.50%
Yıllık değişim
-20.74%
Önceki kapanış
2.0
6
Open
1.7
2
Bid
Ask
Low
1.7
2
High
1.7
2
Hacim
15
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
SEER
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
58.05 M
59.7 M
60.73 M
55.74 M
—
Valuation ratios
Enterprise value
4.02 B
1.07 B
344.48 M
373.54 M
1.26 B
Price to earnings ratio
-19.5
-3.93
-1.44
-1.66
-6
Price to sales ratio
209.81
23.57
7.43
10.16
32.69
Price to cash flow ratio
29.95
6.01
2.1
3.12
10.68
Price to book ratio
2.76
0.82
0.31
0.44
0.73
Enterprise value to EBITDA ratio
-61.69
-12.03
-4.27
-4.41
-16.35
Profitability ratios
Return on assets %
0.13
0.19
0.2
0.24
0.24
Return on equity %
0.14
0.21
0.22
0.26
0.26
Return on invested capital %
214.16
407.85
495.63
347.13
308.12
Gross margin %
51.56
45.78
51.05
49.79
202.95
Operating margin %
1 080.14
627.61
620.99
706.43
2 056.45
EBITDA margin %
-984.1
-571.61
-484.59
-597.54
-1 706.08
Net margin %
1 075.55
600.05
517.84
611.14
1 939.89
Liquidity ratios
Quick ratio
30.36
34.2
24.66
16.04
67.07
Current ratio
30.67
34.57
25
16.53
69.27
Inventory turnover
—
0.12
0.19
0.03
0.02
Asset turnover
0.01
0.03
0.04
0.04
0.05
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.76
0.97
0.93
0.74
0.76
EBIT per share
-1.17
-1.56
-1.62
-1.61
-1.41
EBITDA per share
-1.07
-1.42
-1.26
-1.36
-1.17
Total debt per share
—
—
—
—
—
Cash per share
8.1
6.83
5.84
4.8
18.42
Net current asset value per share
6.76
6.97
5.18
4.06
15.9
Tangible book value per share
8.26
7.16
6.22
5.25
20.28
Working capital per share
6.54
6.77
4.97
3.82
14.97
Book value per share
8.26
7.16
6.22
5.25
20.09
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
Haberler
Seer, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SEER) 2026-02-27
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer’in 4Ç 2025 sunumu: kurulu cihaz tabanı %67 arttı, gelir hedefi tutmadı
Seer Q4 2025 slides: installed base surges 67%, revenue misses mark
Seer kazancı $0,02 ile beklentilere göre daha iyi, kâr ise beklentilere göre düşük
Seer earnings beat by $0.02, revenue fell short of estimates
Seer to showcase proteomics technology at US HUPO conference
İlaç keşfi için protein-gen ilişkilerini doğrulayan kütle spektrometrisi çalışması
Mass spectrometry study validates protein-gene associations for drug discovery
Seer, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SEER) 2025-11-26
CG MedTech Forumu’nda Seer: Proteomik Yenilikleri Öncülük Ediyor
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way